Ryan Weispfenning has elected to take up the challenge of creating and leading the investor relations function at the planned new diabetes company.
Medtronic changes investor relations leadership ahead of diabetes spinout
Ryan Weispfenning has elected to take up the challenge of creating and leading the investor relations function at the planned new diabetes company.